Quantitative magnetic resonance (qMR) biomarkers are increasingly being used as outcomes in clinical trials in Duchenne muscular dystrophy (DMD). However, these measures are predominantly used in the legs, partly due to a lack of natural history data using qMR biomarkers in the upper extremity. The ImagingDMD research group has been working to develop qMR biomarkers that for both nonambulatory and ambulatory boys. Here, we present results from the first year of collection of upper extremity data.

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...